Trelegy Ellipta general drug use investigation (asthma)

05/05/2021
03/07/2025
EU PAS number:
EUPAS40313
Study
Finalised
Subscribe
Download as PDF
Documents
Study protocol
Initial protocol

gsk-214953-protocol-redact

English (191.27 KB - PDF) View document
Study results
Study report
Study report

Clinical_Study_Report_Anonymised.pdf

English (6.21 MB - PDF) View document
Other information